STOCKSCREENR
Log In

SCYX

NASDAQ

SCYNEXIS, Inc.

$0.92+0.02(+2.39%)Mkt Cap: $41.11M

Key Stats

Market Cap

$41.11M

P/E Ratio

-5.11

EPS

$-0.18

Dividend Yield

0.00%

52-Week Range

$0.56 — $1.31

Volume

176.27K

Avg Volume

443.47K

Beta

1.32

Valuation

P/E (TTM)

-5.11

Forward P/E

—

PEG Ratio

-0.06

P/S (TTM)

1.86

P/B (TTM)

0.76

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.19%

ROA (TTM)

-0.15%

ROIC

—

Gross Margin

0.09%

Operating Margin

-0.78%

Net Margin

—

Debt/Equity

0.04

Current Ratio

7.04

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.15%

EPS Growth (5Y)

+0.34%

Sales Growth (3Y)

+8.31%

Sales Growth (5Y)

+4.79%

EPS Est (This Year)

$-0.06

EPS Est (Next Year)

$-0.44

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.92

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

41.97M

Float

32.96M

Free Float %

78.53%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2014-05-02

Employees

28

CEO

David Gonzalez Angulo

Index Membership

—

Website

https://www.scynexis.com

SCYNEXIS, Inc. (SCYX) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $41.11M, a P/E ratio of -5.11, SCYX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SCYX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

ROMJ.V

Rubicon Organics Inc.

$0.51

+4.08%

$34.26M

ASRT

Assertio Holdings, Inc.

$12.50

+6.20%

$80.21M

PCLO.V

PharmaCielo Ltd.

$0.07

+7.69%

$13.16M

TKNO

Alpha Teknova, Inc.

$2.88

-4.32%

$154.33M

CPIX

Cumberland Pharmaceuticals Inc.

$3.01

-1.63%

$45.02M

LOVE.V

Cannara Biotech Inc.

$1.89

+6.18%

$181.03M

Frequently Asked Questions

What is SCYNEXIS, Inc.'s P/E ratio?

SCYNEXIS, Inc. (SCYX) has a trailing twelve-month (TTM) P/E ratio of -5.11. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does SCYNEXIS, Inc. pay a dividend?

No, SCYNEXIS, Inc. (SCYX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is SCYNEXIS, Inc.'s market cap?

SCYNEXIS, Inc. (SCYX) has a market capitalization of $41.11 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.